Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc.filedCriticalMerck & Co. Inc.
Publication of YU34400ApublicationCriticalpatent/YU34400A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Chemical conjugates which comprise oligopeptides, having amino acid sequences that are selectively proteolytically cleaved by free prostate specific antigen (PSA) and known cytotoxic agents are disclosed. The conjugates of the invention are characterized by attachment of the cleavable oligopeptide to the oxygen atom at the 4-position on a vinca drug that has be desacetylated. Such conjugates are useful in the treatment of prostatic cancer and benign prostatic hypertrophy (BPH).
YU34400A1997-12-021998-11-25Conjugates useful in the treatment of prostate cancer
YU34400A
(en)